ResInsightsLive

CME Presentations

Idiopathic Pulmonary Fibrosis


Presentations


Speakers

  • Peter P. LaCamera, MD

    Peter P. LaCamera, MD

    Peter P. LaCamera, MD

    Assistant Professor of Medicine

    Peter P. LaCamera, MD, is Chief, Division of Pulmonary, Critical Care & Sleep Medicine, and the director of the Interstitial Lung Disease Program at St. Elizabeth’s Medical Center in Boston, Massachusetts. Prior to joining St. Elizabeth’s Medical Center, he was a member of the pulmonary and critical care staff at Beth Israel Deaconess Medical Center in Boston, and co-director of its Interstitial Lung Disease Center. Dr LaCamera has participated in numerous clinical trials investigating new therapies for IPF, and is currently the medical director of the ILD Collaborative, an organization composed of patients and physicians working together to advance interstitial lung disease knowledge and care. He received his medical degree from the University of Massachusetts Medical School in Worcester.
  • Barry Shea, MD

    Barry Shea, MD

    Barry Shea, MD

    Assistant Professor of Medicine

    Barry Shea, MD, is director of the Interstitial Lung Disease (ILD) Program at Brown Medicine and Rhode Island Hospital, and assistant professor of medicine at the Warren Alpert Medical School of Brown University in Providence. Dr Shea focuses on the clinical care of individuals afflicted with ILDs, and directs a clinical and translational research program in the field of pulmonary fibrosis. He received his MD from Tufts University School of Medicine in Boston, Massachusetts, and completed his internal medicine residency at New York-Presbyterian Hospital Weill Cornell Medical Center. He completed his clinical training in the Harvard Pulmonary and Critical Care Fellowship Program, followed by a postdoctoral fellowship studying the biology of lung fibrosis at Massachusetts General Hospital.
  • Robert W. Hallowell, MD

    Robert W. Hallowell, MD

    Robert W. Hallowell, MD

    Assistant Professor of Medicine

    Robert W. Hallowell, MD, is an assistant professor of medicine at Harvard Medical School and is the Pulmonary Practice Director at Beth Israel Deaconess Medical Center, both located in Boston, Massachusetts. Dr Hallowell’s research and clinical focus includes idiopathic pulmonary fibrosis and interstitial lung diseases related to underlying rheumatologic conditions. He received his medical degree from Columbia University College of Physicians and Surgeons in New York, and completed his internal medicine and pulmonary/critical care training at Johns Hopkins Hospital in Baltimore, Maryland.

CME Information

Enhancing the Clinical Management of Idiopathic Pulmonary Fibrosis


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Formulate a differential diagnosis for IPF from other interstitial lung diseases
  • Plan to execute timely treatment approaches in consideration of patient health status and certainty of IPF diagnosis
  • Plan effective strategies to manage anticipated disease- and treatment-related side effects associated with IPF

Acknowledgement

This activity is supported by an educational grant from Genentech.

Tuition

Complimentary

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Physician Continuing Education
Live Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Releasae/Expiration

Live Activity
Thursday, June 21, 2018 from 12:00pm – 1:00pm EDT.

Enduring Material
The enduring material will be available from June 21, 2018 to June 21, 2019.

Target Audience

This activity is intended for pulmonologists with a secondary audience of family practitioners, internists, critical care clinicians, advanced practice nurses, and other health care professionals involved in the management of patients with IPF.

Estimated Time to Complete

TThis activity consists of one session which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

Peter P. LaCamera, MD
Assistant Professor of Medicine
Tufts University School of Medicine
Chief, Division of Pulmonary, Critical Care & Sleep Medicine
Director, Interstitial Lung Disease Program
St. Elizabeth's Medical Center

Consulting Fees: Boehringer Ingelheim, Genentech

Robert W. Hallowell, MD
Assistant Professor of Medicine
Harvard Medical School
Co-Director, Interstitial Lung Disease Center
Beth Israel Deaconess Medical Center

None

Barry Shea, MD
Assistant Professor of Medicine
The Warren Alpert Medical School of Brown University
Director, Interstitial Lung Disease Program
Rhode Island Hospital

Consulting Fees: Boehringer Ingelheim, Genentech

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Joe Chebli, PhD
Medical Director
PlatformQ Health Education, LLC

None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Discalimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support:
For any technical issues or issues with your CME Certificate, please contact ResInsightsLive at 877-394-1306 or at Support@ResInsightsLive.com